CME
Latest Episodes
Navigating Adjuvant ICI Treatment in Stage II Melanoma: A Patient Case Presentation
Host: Sapna Patel, MD This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, appropri
What Dermatologists & Surgeons Need To Know: Adjuvant Treatment for Resectable Stage III/IV Melanoma
Host: Jeffrey S. Weber, MD, PhD This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized
Case Consult: Adjuvant Therapy Following Localized Treatment for Stage III Melanoma
Host: Sapna Patel, MD This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, appropri
Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma
Host: Mario E. Lacouture, MD This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, a
Optimizing Resectable Melanoma Outcomes Through Multidisciplinary Care and Multimodal Treatment Strategies
Host: Mario E. Lacouture, MD Host: Sapna Patel, MD This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and s
Unlocking Synergy: Exploring the Interaction Between LAG-3 and Other Immune Checkpoints
Host: Hussein Tawbi, MD, PhD This activity focuses on improving clinician awareness and knowledge of LAG-3-based immunotherapy in metastatic melanoma. We aim to identify patients with metastatic melanoma who can benefit from LAG-3/PD-1 combinati
Future Directions: Targeting LAG-3 in Melanoma Treatment
Host: Hussein Tawbi, MD, PhD This activity focuses on improving clinician awareness and knowledge of LAG-3-based immunotherapy in metastatic melanoma. We aim to identify patients with metastatic melanoma who can benefit from LAG-3/PD-1 combinati
First-Line Treatment of Metastatic Melanoma After Adjuvant Anti-PD-1
Host: Allison Betof Warner, MD, PhD This activity focuses on improving clinician awareness and knowledge of LAG-3-based immunotherapy in metastatic melanoma. We aim to identify patients with metastatic melanoma who can benefit from LAG-3/PD-1 co
Experts on Call: Connecting Specialists and PCPs to Improve Patient-Centered Obesity Management
Host: Robert F. Kushner, MD Host: Donna Ryan, MD Host: Christopher D. Still, DO, FACN, FACP, FTOS Obesity experts review obesity management strategies and provide insight on best practices for implementation in a primary care setting.
Experts on the Ground: Data Updates on Emerging Therapies for IgAN
Host: Richard Lafayette, MD, FACP Expert Nephrologist Richard Lafayette, MD, FACP, gives an overview of top abstracts from Kidney Week 2023 and updates on emerging therapies for IgAN.